CD274 and neoplasm: Multiple factors have been revealed to influence ICI effectiveness, such as the PD-L1 expression level (4, 5), the mutational burden of the tumor (6, 7), and critical signaling pathways such as interferon-γ (IFN-γ) (8, 9).